Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity - 21/12/17
Doi : 10.1016/j.jaci.2017.10.027
Martin Wolf, PhD a, ∗, Lorenz Aglas, PhD a, Teresa E. Twaroch, PhD b, Markus Steiner, PhD a, c, Sara Huber, MSc a, Michael Hauser, PhD a, Heidi Hofer, PhD a, Maria A. Parigiani, MSc a, Christof Ebner, MD d, Barbara Bohle, PhD e, Peter Briza, PhD a, Angela Neubauer, PhD b, Frank Stolz, PhD b, Michael Wallner, PhD a, Fatima Ferreira, DDSc, PhD a 
a Department of Molecular Biology, University of Salzburg, Salzburg, Austria
b Biomay AG, Vienna Competence Center, Vienna, Austria
c Laboratory for Immunological and Molecular Center Research, Paracelsus Medical University, Salzburg, Austria
d Allergy Clinic Reumannplatz, Vienna, Austria
e Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 21 December 2017
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| This study was supported by the Austrian Science Funds (FWF) International PhD Program “Immunity in Cancer and Allergy” (Project W1213), the FWF SFB F4610, the Christian Doppler Research Association (Christian Doppler Laboratory for Allergy Diagnosis and Therapy), and the priority program “Allergy-Cancer-BioNano Research Centre” of the University of Salzburg. |
|
| Disclosure of potential conflict of interest: L. Aglas is employed by the University of Salzburg. S. Huber is employed and a PhD student of the University of Salzburg. H. Hofer is employed by the University of Salzburg; her institution received a Research Fellowship from the University of Salzburg. B. Bohle has been supported by the Austrian Science Funds and by the Christian Doppler Laboratory for Immunomodulation. A. Neubauer and F. Stolz are employees of Biomay AG. M. Wallner has been supported by the Priority Program of the University of Salzburg, the Austrian Science Funds (FWF), and the Austrian Ministry of Science (BMWFW). F. Ferreira is a member of scientific advisory boards (Christian Doppler Research Association, HAL Allergy, SIAF, and AllergenOnline for other works) and has been supported by the Austrian Science Funds (FWF; grant project W1213). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?